TechTaffy

tech:

taffy

AlphaSense raises $100M

By TechTaffy Desk

New York City-headquartered market intelligence and search platform provider AlphaSense has raised $100 million in funding. This is in addition to its $225 million Series D financing round.

Investors in AlphaSense’s latest round include CapitalG, Alphabet’s independent growth fund, and existing investors, including the Growth Equity business within Goldman Sachs Asset Management (Goldman Sachs) and Viking Global Investors.

AlphaSense’s platform and search technology leverages AI and language models, and helps professionals extract relevant insights from an extensive universe of public and private content, including equity research, earnings calls, company filings, news, trade journals, and expert interviews, according to the company.

The latest round pegs AlphaSense at a $1.8 billion valuation, according to the company.

[Image courtesy: AlphaSense]

Just in

Around the web

Windows 11 Start menu ads are now rolling out to everyone — The Verge

Microsoft is starting to enable ads inside the Start menu on Windows 11 for all users, writes Tom Warren. 
Around the web

Biden signs TikTok ‘ban’ bill into law, starting the clock for ByteDance to divest it — The Verge

President Joe Biden signed a foreign aid package that includes a bill that would ban TikTok if China-based parent company ByteDance fails to divest the app within a year, writes Lauren Feiner.
IT

IBM to acquire HashiCorp for $6.4B

IBM and HashiCorp have entered into an agreement for IBM to acquire HashiCorp, a provider of infrastructure and security management products, for $6.4 billion.
AI

OpenAI introduces new enterprise features

OpenAI announced new features aimed at enterprise users on Tuesday, at the wake of Meta's recent LLama 3 announcement.
Around the web

Oracle is moving its world headquarters to Nashville to be closer to health-care industry — CNBC

Oracle Chairman Larry Ellison said Tuesday that the company is moving its world headquarters to Nashville, Tennessee, to be closer to a major health-care epicenter, writes Ashley Capoot.